Increases in airway eosinophils and interleukin-5 with minimal bronchoconstriction during repeated low-dose allergen challenge in atopic asthmatics

被引:81
作者
Sulakvelidze, I [1 ]
Inman, MD [1 ]
Rerecich, T [1 ]
O'Byrne, PM [1 ]
机构
[1] McMaster Univ, Asthma Res Grp, Hamilton, ON, Canada
关键词
airway responsiveness; allergen; asthma; eosinophils; inflammation;
D O I
10.1183/09031936.98.11040821
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Repeated low-dose allergen challenge increases airway hyperresponsiveness in atopic asthmatics. However, it is not known whether low-dose allergen challenge increases airway inflammation. Eight atopic asthmatics mere enrolled in a controlled, cross-over study to evaluate the effect and time course of repeated low-dose allergen challenge on airway inflammation and hyperresponsiveness. The dose of allergen to reduce forced expiratory volume in one second (FEV1) by approximately 5% was selected in a screening allergen challenge, The subjects then were challenged for five consecutive days with either diluent or the selected low-dose of allergen. Methacholine airway hyperresponsiveness (PC20,meth) was measured and sputum induced on days 1, 3 and 5 of the repeated challenge, and then 1 day and 3 days after the last challenge. Repeated low-dose allergen challenge caused small reductions in FEV1, but increased airway eosinophils and interleukin (1L)-5, airway hyperresponsiveness, asthma symptoms and beta(2)-agonist use, all of which peaked on days 3 or 5 of the challenge. The mean (SEM) percentage sputum eosinophils was 21.2 (0.7)% after allergen versus 3.9 (0.1)% after diluent (p<0.001); percentage EG2+ cells were 13.4 (0.3)% after allergen versus 1.1 (0.04)% after diluent (p<0.01) and geometric mean (GSEM) eosinophil cationic protein (ECP) was 1061.8 (1.6) mu g.L-1 after allergen versus 447.03 (1.2) mu g.L-1 after diluent (p<0.05). Geometric mean (GSEM) IL-5 was 71.4 (1.4) pg.mL(-1) after allergen versus 18.4 (1.04) pg.mL(-1) after diluent (p<0.01), All the changes had resolved by 3 days after the last challenges, The study demonstrated that repeated inhalation of a low-dose of allergen causes airway eosinophilia and increases in interleukin-5, associated with airway hyperresponsiveness, and mild worsening of asthma control, without the development of marked acute bronchoconstriction or the development of late responses.
引用
收藏
页码:821 / 827
页数:7
相关论文
共 35 条
[1]  
ALTOUNYAN REC, 1970, DISODIUM CROMOGLYCAT, P47
[2]  
BOOIJ-NOORD H, 1972, Clinical Allergy, V2, P43, DOI 10.1111/j.1365-2222.1972.tb01267.x
[3]   ASTHMA AND INCREASES IN NON-ALLERGIC BRONCHIAL RESPONSIVENESS FROM SEASONAL POLLEN EXPOSURE [J].
BOULET, LP ;
CARTIER, A ;
THOMSON, NC ;
ROBERTS, RS ;
DOLOVICH, J ;
HARGREAVE, FE .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1983, 71 (04) :399-406
[4]   EVIDENCE OF ONGOING MAST-CELL AND EOSINOPHIL DEGRANULATION IN SYMPTOMATIC ASTHMA AIRWAY [J].
BROIDE, DH ;
GLEICH, GJ ;
CUOMO, AJ ;
COBURN, DA ;
FEDERMAN, EC ;
SCHWARTZ, LB ;
WASSERMAN, SI .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1991, 88 (04) :637-648
[5]   EOSINOPHILS EXPRESS INTERLEUKIN-5 AND GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR MESSENGER-RNA AT SITES OF ALLERGIC INFLAMMATION IN ASTHMATICS [J].
BROIDE, DH ;
PAINE, MM ;
FIRESTEIN, GS .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (04) :1414-1424
[6]   ALLERGEN-INDUCED INCREASE IN NONALLERGIC BRONCHIAL REACTIVITY [J].
COCKCROFT, DW ;
RUFFIN, RE ;
DOLOVICH, J ;
HARGREAVE, FE .
CLINICAL ALLERGY, 1977, 7 (06) :503-513
[7]  
COCKCROFT DW, 1979, AM REV RESPIR DIS, V120, P1053
[8]  
COCKCROFT DW, 1987, AM REV RESPIR DIS, V135, P264
[9]   BRONCHIAL REACTIVITY TO INHALED HISTAMINE - METHOD AND CLINICAL SURVEY [J].
COCKCROFT, DW ;
KILLIAN, DN ;
MELLON, JJA ;
HARGREAVE, FE .
CLINICAL ALLERGY, 1977, 7 (03) :235-243
[10]  
DEMONCHY JGR, 1985, AM REV RESPIR DIS, V131, P373